These findings implicate α-ketoglutarate in p53-mediated tumor suppression, suggesting that the buildup of α-ketoglutarate in p53-deficient tumors may drive tumor cell differentiation while counteracting cancer progression. This evidence concerns the gene TP53 and cancer.